Literature DB >> 27957122

Indications For AF Ablation: Before Or After The Failure Of Antiarrhythmic Drug Therapy?

Akira Kimata1, Yoko Ito1, Kentaro Yoshida1.   

Abstract

Catheter ablation of atrial fibrillation (AF) is considered to be better than anti-arrhythmic drug therapy in terms of maintaining sinus rhythm, and therefore, it has rapidly evolved to become a commonly performed procedure in major hospitals throughout the world. However, on the basis of the evidence currently available, we support the current guidelines recommending antiarrhythmic drugs as a first-line treatment in most patients with AF except younger patients with symptomatic paroxysmal AF with no evidence of structural heart disease, given the risk of fatal complications associated with the ablation procedure. We would like to emphasize that center volume and individual procedure experience are significant determinants of procedure-related complications. As another effect of AF ablation, preventing atrial remodeling and progression to persistent AF is also noteworthy. Further long-term data is needed to answer the question of whether ablation can prevent or delay the advance of structural remodeling and improve life prognosis, particularly in younger patients.

Entities:  

Year:  2014        PMID: 27957122      PMCID: PMC4956291          DOI: 10.4022/jafib.1134

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  46 in total

1.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

2.  Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination.

Authors:  Michel Haïssaguerre; Prashanthan Sanders; Mélèze Hocini; Yoshihide Takahashi; Martin Rotter; Frederic Sacher; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

3.  Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.

Authors:  Masateru Takigawa; Atsushi Takahashi; Taishi Kuwahara; Kenji Okubo; Yoshihide Takahashi; Yuji Watari; Katsumasa Takagi; Tadashi Fujino; Shigeki Kimura; Hiroyuki Hikita; Makoto Tomita; Kenzo Hirao; Mitsuaki Isobe
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-03-07

4.  Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.

Authors: 
Journal:  Lancet       Date:  1997-11-15       Impact factor: 79.321

5.  Substrate modification combined with pulmonary vein isolation improves outcome of catheter ablation in patients with persistent atrial fibrillation: a prospective randomized comparison.

Authors:  Stephan Willems; Hanno Klemm; Thomas Rostock; Benedikt Brandstrup; Rodolfo Ventura; Daniel Steven; Tim Risius; Boris Lutomsky; Thomas Meinertz
Journal:  Eur Heart J       Date:  2006-06-16       Impact factor: 29.983

6.  Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation.

Authors:  H Sakamoto; M Kurabayashi; R Nagai; J Fujii
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

7.  Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation.

Authors:  Mauricio I Scanavacca; André D'ávila; José Parga; Eduardo Sosa
Journal:  J Cardiovasc Electrophysiol       Date:  2004-08

Review 8.  Complications in the catheter ablation of atrial fibrillation: incidence and management.

Authors:  Atsushi Takahashi; Taishi Kuwahara; Yoshihide Takahashi
Journal:  Circ J       Date:  2009-01-08       Impact factor: 2.993

9.  CT radiographic findings: atrio-esophageal fistula after transcatheter percutaneous ablation of atrial fibrillation.

Authors:  Angelo P Malamis; Kevin J Kirshenbaum; Surya Nadimpalli
Journal:  J Thorac Imaging       Date:  2007-05       Impact factor: 3.000

10.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

Authors:  David J Wilber; Carlo Pappone; Petr Neuzil; Angelo De Paola; Frank Marchlinski; Andrea Natale; Laurent Macle; Emile G Daoud; Hugh Calkins; Burr Hall; Vivek Reddy; Giuseppe Augello; Matthew R Reynolds; Chandan Vinekar; Christine Y Liu; Scott M Berry; Donald A Berry
Journal:  JAMA       Date:  2010-01-27       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.